Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
17%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
WDNA
90
HOLDINGS
14%
ALSO IN PBE
PBE
27
HOLDINGS
44%
ALSO IN WDNA
SECTOR DRIFT (WDNA minus PBE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
VERACYTE INC | 2.1% | 2.8% | 2.1% |
|
GILEAD SCIENCES INC | 1.9% | 5.2% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.8% | 4.2% | 1.8% |
|
UNITED THERAPEUTICS CORP | 1.7% | 4.7% | 1.7% |
|
AMGEN INC | 1.7% | 5.1% | 1.7% |
WDNA Overweight Relative to PBE
|
NATERA INC | 3.7% |
|
TWIST BIOSCIENCE CORP. | 3.3% |
 |
NOVOZYMES A/S-B SHARES | 2.9% |
|
ELI LILLY & CO | 2.7% |
|
BLUEPRINT MEDICINES CORP. | 2.6% |
|
VERICEL CORPORATION | 2.6% |
|
BRIDGEBIO PHARMA, INC. | 2.4% |
|
AGIOS PHARMACEUTICALS INC | 1.9% |
 |
NOVARTIS AG | 1.7% |
|
BRISTOL-MYERS SQUIBB CO | 1.5% |
WDNA Underweight Relative to PBE
|
ALNYLAM PHARMACEUTICALS INC | -5.8% |
|
ROYALTY PHARMA PLC CLASS A | -5.3% |
|
ILLUMINA INC | -5.0% |
|
BIOMARIN PHARMACEUTICAL INC | -3.8% |
|
ANAVEX LIFE SCIENCES CORP. | -3.5% |
|
INCYTE CORP | -3.5% |
|
AMGEN INC | -3.4% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -3.3% |
|
GILEAD SCIENCES INC | -3.3% |
|
HALOZYME THERAPEUTICS INC | -3.2% |